Sign inJoin waitlistJoin the waitlist

Deric Park

Physician · Regional Cancer Care Associates LLC

Credentials: · · · · · ·

History

Regional Cancer Care Associates LLC
2023–Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
2000–2003
Neurology
1996–2000
Loma Linda University School of Medicine
1992–1996

Research

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha
Oncogene · 2009 · Last of 12 authors · 537 citations
Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy
Journal for ImmunoTherapy of Cancer · 2018 · 398 citations
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells
Review · Neuro-Oncology · 2017 · Last of 7 authors · 222 citations

Russell Lonser
10 papers · 8 as a resident
EO
Edward Oldfield
6 papers
Jeremy Rich
6 papers
AV
Alexander Vortmeyer
5 papers
BW
Brian Williams
5 papers · 3 as a fellow
Martha Quezado
5 papers
RW
Robert Weil
5 papers
Edjah Nduom
4 papers
Amin Kassam
3 papers
Ashlee Seldomridge
3 papers
Jason Sheehan
3 papers
JB
John Butman
3 papers

Clinical trials

Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
Principal investigator · Unknown · Phase 1
Deric M Park MD
2011–2013
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2026–2040